Press releases

Communique from the Annual General Meeting in Eevia Health Plc

The Annual General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on June 21, 2022 in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters:

1. Annual report and results

The Annual General Meeting adopted the income statement and the balance sheet for the financial year 2021 and resolved that the net loss of 2,635,577.02 EUR - shall be transferred to retained earnings/loss account. No dividends are to be paid.

  2. Discharge from Liability

The Annual General Meeting granted the Members of the Board of Directors and the Chief Executive Officer discharge from liability for the management of the Company's business for the financial year 2021.

  3. Election of the Members of the Board of Directors

The Annual General Meeting resolved, for the time until the end of the next Annual General Meeting, to re-elect Martin Bjørklund, Per Benjaminsen, Magne Ruus Simensen, and Johanna Panula, and elect Oskar Wegelius as Members of the Board of Directors.  Martin Bjørklund was elected as the Chairman of the Board of Directors.

 4. Remuneration to the Board of Directors

The Annual General Meeting resolved that the Chairman shall receive remuneration of EUR 20,000 and that every other Board Member shall receive remuneration of EUR 10,000.

 5. Election and remuneration of the Auditor

The Annual General Meeting resolved to re-elect PricewaterHouse Coopers Oy as auditor, with Riitta Ulvinen as the principal auditor.  It was resolved that the auditor shall receive remuneration according to the approved invoice.

For further information, please contact:

Gabriella Beni

CFO, Eevia Health Plc

Email: gabriella@eeviahealth.com

Telephone: +358 407 48 8666

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product; Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, Chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. The factory operates near the raw material harvest areas. A uniquely short value chain enables an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth. 

2022-09-22
Regulatory

Notice is given to the shareholders of Eevia Health Abp (Plc) to the Extraordinary General Meeting to be held on 11 October 2022 at 12:00 (Finnish time GMT +3) at the main office of Eevia Health Abp in Koulukatu 14, Seinäjoki, Finland.

The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 11:00.

2022-09-06

Eevia Health Plc, ("Eevia" or "The Company"), has received two small starting sales orders from South Korea and Taiwan, totaling approx. 24 KEUR for organically certified bilberry extracts.

2022-08-29
Regulatory

Eevia Health Plc ("Eevia" or "The Company") is releasing its quarterly financial report for the second quarter of 2022.

2022-07-25

Eevia Health Plc ("Eevia" or "The Company") is welcoming Tuomas Jylhä as interim Chief Financial Officer. Gabriella Beni has decided to leave the Company for personal reasons to focus on private matters. Eevia wishes her the very best in her future endeavors. Tuomas Jylhä will take over the position on July 26th.

2022-07-08

Analyst Group Initiates equity research Coverage of Eevia Health Plc, ("Eevia" or "The Company").

2022-07-06
Regulatory

Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from its Australian distributor Ingredients Plus.

2022-06-27

Eevia Health Plc, ("Eevia" or "The Company"), has received a 21 KEUR sales order from its Australian distributor Ingredients Plus for a new product made from Lingonberry, after a new customer has decided to launch a new product with the Lingonberry ingredient as a key component.

2022-06-24
Regulatory

Eevia Health Plc, ("Eevia" or "The Company"), has entered into an agreement whereby Exelity AB, Sweden will provide a credit line for Eevia of up to SEK 8 million, giving the Company increased working capital flexibility to finance its continued growth.

2022-06-21

The Annual General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on June 21, 2022 in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters:

2022-06-09

Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania.

1
2
3
4
5